• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Tue, 17.11.26

Search results


November 2026
Arieh Riskin MD PhD, Ayala Gover MD

Sociodemographic biases, which are related to gender, race and ethnicity, socioeconomic status, age, weight, and sexual orientation, permeate medical decision-making and contribute to health disparities that affect diagnosis, treatment allocation, and patient outcomes. In this narrative review, we address sociodemographic bias in general, treating implicit bias as one of several mechanisms. Drawing on peer-reviewed studies, systematic reviews, and meta-analyses published mainly between 2010 and 2025, we examined evidence for these biases, their mechanisms, bias in artificial intelligence (AI) and large language model (LLM) clinical tools, and interventions for bias reduction. We integrated literature usually reviewed separately and distinguished evidence of outcome disparities from evidence that directly measures clinician bias. Robust evidence documents gender disparities in cardiovascular care and pain management, racial and ethnic disparities in procedural access and analgesia, and socioeconomic gradients in treatment intensity.

Experimental studies that hold the clinical presentation constant confirm that these patient characteristics can influence clinicians’ decisions. LLMs replicate and sometimes amplify these biases. Up to 91.7% of reviewed studies identified biases in medical AI, with LGBTQ+ patients receiving mental health referrals six to seven times more frequently than clinically warranted. Mechanisms operate at the clinician level (prototype-based reasoning, implicit and explicit attitudes, cognitive load), the knowledge level (non-representative research and training data), and the system level (structural inequity). Multilevel interventions, such as individual bias awareness, structural protocols, and algorithmic fairness techniques, show promise but require sustained institutional commitment. Equity in healthcare is not only an ethical imperative but a clinical and scientific one.

September 2022
Shaul Gelikas MD MBA, Dotan Yaari MD MHA, Guy Avital MD, Or Bainhoren MD, and Avi Benov MD MHA

Background: Pain management is fundamental in the treatment of a trauma casualty. Adequate pain management is associated with decreased long-term morbidity and chronic pain. Nonetheless, pain is frequently not documented nor adequately treated in the prehospital setting, a phenomenon described as oligoanalgesia. Gender bias has been suggested as a risk factor for oligoanalgesia.

Objectives: To examine the association between casualty gender and pain management in the prehospital trauma setting.

Methods: We conducted a retrospective cohort study of the Israel Defense Forces Trauma Registry between 2015 and 2020. Univariable analysis followed by multivariable logistic regression was used to assess the association between casualty gender and pain management. For adult patients for whom gender was known, pain scores were documented.

Results: A total of 1044 casualties were included in the study; 894 (85.6%) were male. Females and males differed in several demographic and injury characteristics, including age in years (mean 36 vs. 27.6, P value < 0.001) and injury mechanism (16%% vs. 34.5% penetrating injury, P value < 0.001). Female casualties were less likely to be treated for pain (odds ratio [OR] 0.708, 95% confidence interval [95%CI] 0.5–1, P = 0.05). However, after adjustment for various factors, including pain severity, this association was insignificant (OR 0.748, 95%CI 0.46–1.23, P = 0.25).

Conclusions: In this prehospital study, gender bias in pain management was not apparent. As women’s role on the battlefield continues to increase, further studies regarding the role of

July 2003
N. Levine, M. Mor and R. Ben-Hur

Background: Multiple sclerosis is a chronic demyelinating disease of the central nervous system that presents with variable signs and symptoms. This variability in the clinical presentation may result in misdiagnosis, unnecessary referrals and misleading information to the patients.

Objectives: To identify the types of misdiagnoses made on the presentation of MS.

Methods: Fifty consecutive MS patients were questioned on their early symptoms, their mental status, the disease course until the diagnosis was confirmed, and the different diagnoses they received.

Results: The patients had been referred to 2.2 ± 1.3 specialists before seeing a neurologist, and learned about their disease 3.5 years after the onset of symptoms. Twenty-nine patients (58%) were initially given 41 wrong diagnoses. While the majority of women were misdiagnosed mentally, orthopedic work-up was offered to the men. Misdiagnosis of MS occurred most often in patients who presented with non-specific sensory symptoms that did not conform to a specific neurologic syndrome. The patients emphasized the fact that not knowing worsened their anxiety, whereas receiving the diagnosis enabled them to begin coping with their disease.

Conclusions: MS is often overlooked when patients present with non-specific sensory complaints. The difference in type of misdiagnosis between men and women may reflect a gender-dependent bias in the way physicians interpret sensory complaints.

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel